All In Biotech

Drug Trial Radar · NCT07668518

A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of KIT2014 in Patients With Moderate to Severe COPD

A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Dose Ranging, Phase 1b/2a Study to Investigate the Safety, Tolerability, Pharmacokinetics and Early Efficacy of Inhaled KIT2014 Over 7 Days of Treatment in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Last checked: Nov 19, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

36

Planned (sponsor's estimate)

Start

Aug 5, 2026

Primary completion

Mar 31, 2027

Study completion Jul 31, 2027

Sponsor

Lead sponsor
Kither Biotech SrlIndustry
Sponsor type
Industry
Collaborators
Avance Clinical Pty Ltd.
First posted
Jun 25, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Randomized
Model
Sequential
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 40 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Study investigating the safety, tolerability, pharmacokinetics and early efficacy with KIT2014 over 7 days of treatment in moderate to severe chronic obstructive pulmonary disease patients.

Conditions

  • Chronic Obstructive Pulmonary Disease (COPD)

Interventions

  • KIT2014Drug

    KIT2014 will be administered by inhalation with a nebuliser

  • PlaceboDrug

    Placebo will be administered by inhalation with a nebuliser

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Treatment-emergent adverse events(TEAEs),serious adverse events(SAEs)Time frame: From first dose to post-treatment follow up visit on Day 9.

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Novatrials

    Charlestown, New South Wales, Australia · Recruiting

  • Emeritus Research Sydney

    Sydney, New South Wales, Australia · Not yet recruiting

  • Emeritus Research

    Camberwell, Victoria, Australia · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.